Trial Information

Summary: Injections of adult stem cells in patients with refractory chronic myocardial ischemia.

The purpose of this study is to evaluate the effectiveness and safety of intramyocardial injections (injections in your heart) of adult stem cells (your own stem cells) in patients with refractory chronic myocardial ischemia (chronic angina/chest pain.)

INCLUSION:

• = 21 and = 80 years of age
• CCS functional class III or IV chronic refractory angina
• Unsuitable for conventional revascularization

EXCLUSION:

• Predominant congestive heart failure
• Left ventricular ejection fraction of less than 25% at screening
• Myocardial infarction within 60 days of treatment
• Successful coronary revascularization within 6 months of study enrollment
• History of moderate to severe aortic stenosis or prosthetic aortic valve
• Co-morbidity associated with life expectancy of less than 1 year

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: June 1, 2008 at 6:32:00 AM